These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19548019)

  • 1. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.
    Armamento-Villareal R; Napoli N; Diemer K; Watkins M; Civitelli R; Teitelbaum S; Novack D
    Calcif Tissue Int; 2009 Jul; 85(1):37-44. PubMed ID: 19548019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual mid-shaft fractures during long-term bisphosphonate therapy.
    Odvina CV; Levy S; Rao S; Zerwekh JE; Rao DS
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):161-8. PubMed ID: 19302584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.
    Chapurlat RD; Arlot M; Burt-Pichat B; Chavassieux P; Roux JP; Portero-Muzy N; Delmas PD
    J Bone Miner Res; 2007 Oct; 22(10):1502-9. PubMed ID: 17824840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low-energy femoral shaft fractures and bisphosphonate use.
    Fowler JR; Craig MR
    Orthopedics; 2012 Jan; 35(1):e38-40. PubMed ID: 22229611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP
    Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone Cell Biology Assessed by Microscopic Approach. The effects of bisphosphonates on bone remodeling, microdamage accumulation and fracture repair process].
    Mashiba T
    Clin Calcium; 2015 Oct; 25(10):1537-40. PubMed ID: 26412734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical fractures as a potential complication of long-term bisphosphonate therapy.
    Sellmeyer DE
    JAMA; 2010 Oct; 304(13):1480-4. PubMed ID: 20924014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib.
    Komatsubara S; Mori S; Mashiba T; Li J; Nonaka K; Kaji Y; Akiyama T; Miyamoto K; Cao Y; Kawanishi J; Norimatsu H
    J Bone Miner Res; 2004 Jun; 19(6):999-1005. PubMed ID: 15125797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation in fracture patients treated with oral bisphosphonates.
    Abrahamsen B; Eiken P; Brixen K
    J Intern Med; 2009 May; 265(5):581-92. PubMed ID: 19141097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teriparatide following bisphosphonates: initial and long-term effects on microarchitecture and bone remodeling at the human iliac crest.
    Jobke B; Pfeifer M; Minne HW
    Connect Tissue Res; 2009; 50(1):46-54. PubMed ID: 19212852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Femur fractures caused by long-term bisphosphonate therapy].
    Somford MP; Thomassen BJ; Draijer WF
    Ned Tijdschr Geneeskd; 2010; 154():A1218. PubMed ID: 20619008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Goddard MS; Reid KR; Johnston JC; Khanuja HS
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural, densitometric and biomechanical evaluations of Chinese patients with long-term bisphosphonate treatment.
    Leung KS; Tang N; Griffith J; Choy TK; Hung VW; Mok HW; Shi L; Leung PC; Cheung WH
    Chin Med J (Engl); 2013 Jan; 126(1):27-33. PubMed ID: 23286473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of bisphosphonates.
    Abrahamsen B
    Calcif Tissue Int; 2010 Jun; 86(6):421-35. PubMed ID: 20407762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
    Patel V; Graves L; Lukert B
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bisphosphonate therapy for osteoporosis and bone strength].
    Kishimoto H
    Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.